Get started
Author

Damla Günenç

Prognostic utility of the CALLY index in metastatic melanoma: building a nomogram for Patients on Anti-PD-1 therapy
2025 · Caner Acar, Haydar Çağatay Yüksel, et al. · Clinical & Translational Oncology · 25
Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs
2023 · Tian Zhang, Patrick M Forde, et al. · Journal for ImmunoTherapy of Cancer · 23
PDF
Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study
2022 · Hasan Çağrı Yıldırım, Emel Mutlu, et al. · The Breast · 22
Prognostic Value of Blood-Based Inflammatory Markers in Cancer Patients Receiving Immune Checkpoint Inhibitors
2024 · Mustafa Murat Midik, Damla Gunenc, et al. · Cancers · 21
PDF
Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model
2017 · Banu Taskin, Mümin Alper Erdoğan, et al. · Gastroenterology Research and Practice · 19
PDF
RAS Mutations in Advanced Colorectal Cancer: Mechanisms, Clinical Implications, and Novel Therapeutic Approaches
2025 · Osman Sütcüoğlu, Hasan Çağrı Yıldırım, et al. · Medicina · 13
PDF
A Narrative Review of RAS Mutations in Early-Stage Colorectal Cancer: Mechanisms and Clinical Implications
2025 · Hasan Cagri Yildirim, Damla Gunenc, et al. · Medicina · 11
Pathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductive Nephrectomy (CN)
2024 · Damla Gunenc, Wadih Issa, et al. · Clinical Genitourinary Cancer · 11
PDF
Tocilizumab in the treatment of steroid refractory immune-related hepatotoxicity: a case series and review of the literature
2024 · Ahmet Anil Ozluk, Damla Gunenc, et al. · Melanoma Research · 10
Predicting immune-related adverse events in patients with melanoma: the role of interleukin-7 rs16906115 polymorphism and lymphocyte dynamics
2025 · Fatma Pınar Açar, Caner Acar, et al. · Frontiers in Immunology · 9
PDF
C-reactive protein kinetics as prognostic biomarkers in advanced melanoma treated with immune checkpoint inhibitors
2025 · Caner Acar, Haydar Çağatay Yüksel, et al. · Melanoma Research · 7
Real-World Treatment Outcomes in Patients With Ga68-PSMA-PET Positive Metastatic Hormone-Sensitive Prostate Cancer With or Without Conventional Imaging Correlates
2025 · Wadih Issa, Maureen Aliru, et al. · Clinical Genitourinary Cancer · 2
Immunotherapy-induced granulomatous reaction in patients with melanoma
2022 · Halil Taskaynatan, Damla Gunenc, et al. · Melanoma Research · 2
PDL-1 Expression and Survival in Metastatic Non-small Cell Lung Cancer Patients Who Received Chemotherapy as First-Line Treatment
2021 · Pınar Gürsoy, Burcu Çakar, et al. · Turkish Thoracic Journal · 2
Claudin-4 Overexpression Predicts Poor Survival and Platinum Resistance in Epithelial Ovarian Cancer: A Potential Biomarker for Clinical Decision-Making
2025 · Özlem Kutlu, Damla Günenç, et al. · Diagnostics · 1
PDF
Abstract 1966: Evaluation of circulating tumor cells as a real-time biomarker in metastatic urothelial carcinoma
2025 · Wadih Issa, Navneet Kaur, et al. · Cancer Research · 1
Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)
2025 · Nargiz Majidova, Sendag Yaslıkaya, et al. · The Turkish Journal of Gastroenterology · 1
PDF
Treatment outcomes for patients with Ga68-PSMA-PET prostate cancer (PC) with or without conventional imaging correlates.
2024 · Wadih Issa, Maureen Aliru, et al. · Journal of Clinical Oncology · 1
Demonstration of PTZ-Induced Convulsive-Reducing Effect of Butamirate Citrate
2018 · Mumin Alper Erdogan, Bilge Piri Cinar, et al. · NeuroQuantology · 1
Evaluation of Olaparib Efficacy Following CDK4/6 Inhibitor Therapy in BRCA-Mutated, Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Turkish Oncology Group (TOG) Study
2026 · Zeynep Sıla Gökdere, Taha Koray Şahin, et al. · Targeted Oncology
Immunoscore and Post-Neoadjuvant Pathological Features in Microsatellite-Stable Locally Advanced Gastric Cancer: A Retrospective Cohort Study
2026 · Özlem Kutlu, Gürkan Gül, et al. · Cancers
Association of Baseline Serum DKK-1 Levels with Subsequent Bone Metastasis in Stage III Breast Cancer
2026 · Gürkan Gül, Damla Günenç, et al. · Medicina
Tumour–Stroma Ratio and Platinum Resistance in Epithelial Ovarian Cancer: An Exploratory Analysis
2026 · Gürkan Gül¹, Özlem Kutlu¹, et al. · Cancers
Real-world outcomes of second-line therapy in advanced thymic carcinoma: a multicenter Turkish Oncology Group (TOG) study
2026 · Fatih Kus, Fatih Atalah, et al. · BMC Cancer
63P Biologic sequencing of bevacizumab and anti-EGFR therapy in MSS RAS/BRAF wild-type right-sided metastatic colorectal cancer
2026 · O. Kutlu, G. Gül, et al. · Annals of Oncology
PDF
Works count: 40
Citation count: 182
H-index: 9
I10-index: 9
Year
Topic
Type